Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GUFICBIO | NSE
19.95
4.99%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
11/09/2024
420.10
401.15
434.00
398.70
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs) generic pharmaceuticals and related services in India. It manufactures APIs and bulk drugs such as antifungals anesthetics immuno suppressants and intermediates for antifungals. The company also manufactures lyophilized injections which include antibiotic antifungal cardiac infertility antiviral and proton-pump inhibitor segments. In addition it offers spark criti care and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai India.
View LessPositive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
36.0%1 month
42.2%3 months
33.9%6 months
45.5%45.04
-
7.36
0.63
0.30
28.87
5.52
-
1.47B
40.98B
487.98M
0.03
15.52
-2.30
4.00
19.57
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
48.75
Range1M
96.50
Range3M
109.30
Rel. volume
2.93
Price X volume
316.63M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 589.6 | 41.29B | 2.94% | n/a | 10.48% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2260.05 | 41.18B | -6.00% | 43.66 | 0.00% |
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 155.01 | 40.96B | -1.93% | 14.53 | 0.42% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 378.45 | 36.64B | 0.16% | 45.86 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 154.26 | 35.72B | 0.92% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 755 | 34.48B | -1.87% | n/a | 107.90% |
IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 463 | 29.11B | -4.28% | 23.04 | 2.03% |
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 24.61 | 26.15B | -4.87% | 61.34 | 25.16% |
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 789.1 | 22.74B | -1.02% | 54.96 | 0.60% |
Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 249.9 | 22.62B | 0.06% | 44.25 | 25.36% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1040.7 | 34.23B | -1.36% | 135.14 | 191.28% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 34.51 | 31.84B | -4.69% | 85.67 | 10.74% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 170.16 | 26.42B | -1.14% | 30.68 | 43.67% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 218.33 | 22.22B | 0.06% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 99.31 | 3.21B | -0.33% | 34.72 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 148.56 | 1.64B | -1.86% | 47.02 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 100.43 | 1.56B | -3.20% | 36.75 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.86 | 998.75M | -1.17% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.36 | 498.80M | 0.93% | 89.06 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.75 | 330.30M | 2.43% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 28.87 | - | Expensive |
Ent. to Revenue | 5.52 | - | Cheaper |
PE Ratio | 45.04 | 50.21 | Par |
Price to Book | 7.36 | 6.64 | Par |
Dividend Yield | 0.03 | - | Poor |
Std. Deviation (3M) | 33.90 | - | Par |
Debt to Equity | 0.63 | 0.34 | Expensive |
Debt to Assets | 0.30 | 0.16 | Expensive |
Market Cap | 40.98B | - | Emerging |